Principal Investigator, Dept. Of Molecular Cell Biology,
Weizmann Institute of Science
One of the main barriers for successful treatments of glioma is the diversity of cells within each tumor. We have previously defined the patterns of cellular diversity in several types of glioma, including glioblastoma and
IDH-mutant glioma, highlighting few recurring cellular states in each glioma type.
I will describe recent studies in which
we examine how these states are spatially organized and how they change following treatments and recurrence. Spatially, we find that some tumor samples are disorganized while others have a stereotypical organization composed of five layers. These layers highlight the role of hypoxia as a tissue organizer. We also explore the states of cells outside of the tumor – those that invade the brain parenchyma and
that cause gliomas to recur. Following treatments, we find that cells in most gliomas maintain largely the same states that are observed in the primary tumors.
However, tumors with evidence of treatment response show specific signatures of those responses. In particular, in IDH-mutant glioma we find that new treatments induce cellular differentiation, highlighting the potential of differentiation therapies in the context of glioma.
Lecture:
CHL – Centre
Room: Amphitheatre
4, rue Ernest Barblé
L-1210 Luxembourg
LECTURE: 11:00am – 12:00pm
Webinar via Webex:
Event number: 2790 737 8560
Event password: krV4pwb5ZZ9
12:00pm – 13:00pm
Room Barbara Mc Clintock
Light lunch provided – *Please note that registration for Meet and Eat is mandatory via the following link:
Supported by:
Read more about the “Data Protection Notice: processing of personal data in the scope of events’ management”.